WallStreetZenWallStreetZen

NASDAQ: APGE
Apogee Therapeutics Inc Stock Ownership - Who owns Apogee Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Apogee Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Carl DambkowskiChief Medical Officer2025-04-02500$37.03
$18.52kSell
Carl DambkowskiChief Medical Officer2025-04-02889$37.59
$33.42kSell
Carl DambkowskiChief Medical Officer2025-04-022,471$35.56
$87.87kSell
Michael Thomas HendersonChief Executive Officer2025-03-057,326$29.98
$219.63kSell
Michael Thomas HendersonChief Executive Officer2025-03-052,674$30.62
$81.88kSell
Carl DambkowskiChief Medical Officer2025-03-051,590$30.48
$48.46kSell
Carl DambkowskiChief Medical Officer2025-02-05795$22.86
$18.17kBuy
Michael Thomas HendersonChief Executive Officer2025-02-0515,000$40.58
$608.70kSell
Carl DambkowskiChief Medical Officer2025-02-053,520$40.69
$143.23kSell
Michael Thomas HendersonChief Executive Officer2025-01-318,500$22.86
$194.31kBuy

1 of 5

APGE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APGE insiders and whales buy or sell their stock.

APGE Shareholders

What type of owners hold Apogee Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vr Adviser LLC14.27%8,493,321$281.21MInstitution
Fmr LLC12.60%7,499,382$248.30MInstitution
Wellington Management Group LLP7.59%4,517,363$149.57MInstitution
Blackrock Inc5.12%3,044,958$100.82MInstitution
Rtw Investments LP4.56%2,712,097$89.80MInstitution
Driehaus Capital Management LLC4.38%2,605,310$86.26MInstitution
Fairmount Funds Management LLC3.61%2,150,979$71.22MInsider
Vanguard Group Inc3.53%2,097,597$69.45MInstitution
Fairmount Funds Management LLC3.44%2,048,647$67.83MInstitution
Nimish P. Shah2.94%1,750,000$57.94MInsider

1 of 3

APGE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APGE90.99%9.01%Net SellingNet Selling
DNLI60.04%39.96%Net Selling
FOLD65.48%34.52%Net SellingNet Selling
LGND16.60%83.40%Net SellingNet Selling
MIRM50.40%49.60%Net SellingNet Selling
View Top Biotech Stocks

Apogee Therapeutics Stock Ownership FAQ

Who owns Apogee Therapeutics?

Apogee Therapeutics (NASDAQ: APGE) is owned by 97.25% institutional shareholders, 9.63% Apogee Therapeutics insiders, and 0.00% retail investors. Fairmount Funds Management LLC is the largest individual Apogee Therapeutics shareholder, owning 2.15M shares representing 3.61% of the company. Fairmount Funds Management LLC's Apogee Therapeutics shares are currently valued at $70.66M.

If you're new to stock investing, here's how to buy Apogee Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.